Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on September 25, 2026

Sep. 25, 2026

Silly Nice Launches THE FIELD MANUAL, a National Cannabis Education Resource Built for U.S. Veterans

Indeterminate GlobeNewswire

Sep. 25, 2026

BioSyent Named as One of Canada’s Top Growing Companies 2026 by The Globe and Mail

Indeterminate GlobeNewswire

Sep. 25, 2026

Fangzhou Releases 2026 Interim Report, Deepening "AI + Chronic Care" as a Lifetime Health Service Partner

Indeterminate GlobeNewswire

Sep. 25, 2026

Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026

Indeterminate GlobeNewswire

Sep. 25, 2026

Kraig Labs’ Atlas Milestone Opens the Door to Potential Historic Spider Silk Advancements

Indeterminate GlobeNewswire

Sep. 25, 2026

Knowtex, the First Frontier AI Lab for Healthcare, Named Prime Awardee on VA's Nine-Figure Ambient Scribe Enterprise Contract

Indeterminate GlobeNewswire

Sep. 25, 2026

CIRM awards $9 million to Enloe Health to bring cell and gene therapies closer to patients in Northern California

Indeterminate GlobeNewswire

Sep. 25, 2026

INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference

Indeterminate GlobeNewswire

Sep. 25, 2026

SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026

Indeterminate GlobeNewswire

Sep. 25, 2026

National Association of Specialty Pharmacy Honors Poster Award Winners and Scholarship Recipients at inSPire2026

Indeterminate GlobeNewswire

Sep. 25, 2026

Tilray Brands to Announce First Quarter Fiscal Year 2027 Financial Results on October 8, 2026

Indeterminate GlobeNewswire

Sep. 25, 2026

Teladoc Health Announces Chief Legal Officer Transition

Indeterminate GlobeNewswire

Sep. 25, 2026

CDT Equity Inc. Announces Reverse Stock Split

Indeterminate GlobeNewswire

Sep. 25, 2026

Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure

Indeterminate GlobeNewswire

Sep. 25, 2026

neurocare and Wave Neuroscience partner to expand patient access to FDA-Cleared MeRT® therapy for PTSD on the Apollo TMS Therapy System

Indeterminate GlobeNewswire

Sep. 25, 2026

Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD

Indeterminate GlobeNewswire

Sep. 25, 2026

Cerenome to Hold CNSide® Business Update Call on September 30, 2026

Indeterminate GlobeNewswire

Sep. 25, 2026

Ocugen Receives Provisional Approval and Priority Designation Under the Longevity and Regenerative Therapies Act in The Bahamas to Provide OCU400 to Patients for Treatment of Retinitis Pigmentosa

Indeterminate GlobeNewswire

Sep. 25, 2026

Legend Biotech Presents CARVYKTI Data Showing Half of Patients with RRMM Remained Progression-Free and Alive Five Years After a Single Infusion

Indeterminate GlobeNewswire

Sep. 25, 2026

C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society (IMS) Annual Meeting

Indeterminate GlobeNewswire